Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Xediton Pharmaceuticals
Quantum Genomics to receive up to $11.35 million in upfront and milestone payments plus double-digit royalties on sales Xediton Pharmaceuticals to receive an exclusive license to develop and commercialize firibastat for the treatment of difficult to treat/ …